September 2016 Newsletter

We would like to thank our clients and colleagues for the growth in demand for our "hard to find", potent primary cells. You make our success possible.

This month we feature research using our Human Mesenchymal Stem Cells and i-Fect Transfection Kit. Both are step towards related Cell Based Therapies.

Targeted Delivery of Human Stem Cells

Yun Seop Kim, Won Ho Kong, Hyemin Kim, Sei Kwang Hahn. Targeted Systemic Mesenchymal Stem Cell Delivery Using Hyaluronate - Wheat Germ Agglutinin Conjugate. MSCs (hMSCs) were purchased from Neuromics Co...

Images: Fluorescence microscopic images of dissected livers and lungs from normal rats 4 h after intravenous injection of PBS, WGA-FITC/hMSC, and HA-WGA-FITC/hMSC (Filter for FITC). (b) Quantification of hMSCs in dissected organs estimated from ROI (n = 3). **P versus the WGA/hMSC group. (c) Representative fluorescence microscopic images of WGA-FITC/hMSC and HA-WGA-FITC/hMSC in the liver and lung (green = FITC, blue = DAPI for nucleus). Arrows indicate the location of hMSCs (scale bar = 200 μm).
Epigenetics and Pain

M. Leinders, b, N. Üçeyler, R.A. Pritchard, C. Sommer, L.S. Sorkin. Increased miR-132-3p expression is associated with chronic neuropathic pain. Experimental Neurology. Volume 283, Part A, September 2016, Pages 276–286...The inhibitor and mimetic were administered to awake rats via the it catheters. Prior to injection, active or mismatch inhibitors were mixed with (1:5 w/v) i-Fect™ in vivo transfection reagent(Neuromics, Edina, USA) to final doses of 5, 2 and 1 μg in 10 μl..

Need hard to find human cells? Please contact me directly or 612-801-1007. We can together determine your needs and desired outcomes and provide a statement of work with pricing, project milestones and delivery.

We wish you a productive September filled with new and exciting discoveries.

Pete Shuster-Owner and CEO, or 612-801-1007

Rose Ludescher-Manager of Customer or 866-350-1500